FDA official logo
GSRS logoPFDA official logo

MIRVETUXIMAB SORAVTANSINE

UNII:98DE7VN88D
Formula:
Preferred Substance Name:MIRVETUXIMAB SORAVTANSINE

  • 1453084-37-1
  • ELAHERE
  • IMGN853
  • IMGN-853
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN FOLATE RECEPTOR .ALPHA.) (HUMAN-MUS MUSCULUS MONOCLONAL M9346A HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL M9346A LIGHT CHAIN, DIMER, TETRAAMIDE WITH N2'-(4-((3-CARBOXY-3- SULFOPROPYL)DITHIO)-4-METHYL-1-OXOPENTYL)-N2'-DEACETYLMAYTANSINE
  • IMMUNOGLOBULIN G1-KAPPA, ANTI-(HUMAN FOLATE RECEPTOR ALPHA (ADULT FOLATEBENDING PROTEIN, FOLATE RECEPTOR 1, KB CELLS FBP, OVARIAN TUMOR-ASSOCIATED ANTIGEN MOV18)); HUMANIZED MOUSE MONOCLONAL ANTIBODY LINKED TO AN AVERAGE OF FOUR MOLECULES OF MAYTANSINE ACID DERIVATIVE : AMIDE BETWEEN AN AVERAGE OF FOUR MOLECULES OF (2RS,12S)-14-((1S,2R,3S,5S,6S,16E,18E,20R,21S)-11- CHLORO-21-HYDROXY-12,20-DIMETHOXY-2,5,9,16-TETRAMETHYL-8,23-DIOXO-4,24- DIOXA-9,22-DIAZATETRACYCLO(19.3.1.110.14.03.5)HEXACOSA-10,12,14(26),16,18- PENTAEN-6-YL)-7,7,11,12-TETRAMETHYL-10,13-DIOXO-2-SULFONYL-14-OXA-5,6-DITHIA11-AZATETRADECANOIC ACID AND AN AVERAGE OF FOUR AMINO GROUPS OF .GAMMA.1 HEAVY CHAIN (1-447) (MUS MUSCULUS VH (IGHV1-37*01-(IGHD)-IGHJ4*01) (88%) (8.8.11) (1-119) -DES-(CH3K107 (448))-IGHG1*01 (119-447)) (221-218')- DISULFIDE WITH KAPPA LIGHT CHAIN (1'-218') (MUS MUSCULUS V-KAPPA (IGKV3-9*01-IGKJ1*02) (81%) (10.3.9) (1'-111') -IGKC*01 (112'-218')) DIMER (227-227'':230-230'')-BISDISULFIDE
  • MIRVETUXIMAB SORAVTANSINE [INN]
  • MIRVETUXIMAB SORAVTANSINE [USAN]
  • MIRVETUXIMAB SORAVTANSINE [WHO-DD]
  • MIRVETUXIMAB SORAVTANSINE-GYNX




UNII - 98DE7VN88D | UNII Search Service